Trial Profile
Mabthera [rituximab] in remission induction and maintenance treatment of relapsed follicular lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2005
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Vincristine
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 03 Aug 2005 New trial record.